Jubilant Pharmova informs about investment updates

01 Jun 2021 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jubilant Pharmova has informed that it enclosed a communication pertaining to investment of $92 million by Jubilant Pharma, a wholly-owned subsidiary of the Company for expansion of sterile injectable manufacturing capacity at the Spokane site in Washington, US.

The above information is a part of company’s filings submitted to BSE.

Jubilant Pharmova Share Price

810.00 -10.85 (-1.32%)
10-Mar-2026 15:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1813.00
Dr. Reddys Lab 1315.70
Cipla 1333.10
Zydus Lifesciences 923.95
Lupin 2344.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×